Find uplifting stories about heroes, innovations, and solutions
55 results for "glioblastoma"
A $50,000 grant is helping Canadian researchers unlock why the deadliest brain cancer resists treatment that works for other cancers. The early-stage work could lead to the first effective immunotherapy for glioblastoma patients.
A South Carolina mother has defied medical odds by surviving glioblastoma, one of the deadliest brain cancers, for 15 years. Her story offers hope to families facing similar diagnoses.
Scientists at UCLA built miniature 3D brain models that reveal why the deadliest brain cancer resists treatment, opening doors to personalized therapies. These lab-grown organoids mimic real human brains, showing for the first time how tumors communicate with healthy cells to become more aggressive.
Researchers discovered a protein pathway that could make glioblastoma, the most aggressive brain tumor, finally vulnerable to treatment. The breakthrough could extend survival beyond the current 14-month median for patients facing this devastating diagnosis.
Scientists at McMaster University discovered how deadly glioblastoma grows and identified an existing HIV medication that could fight it. The breakthrough could fast-track treatment for patients who currently have few options.
Scientists at the University of Virginia have discovered a pill that stops glioblastoma, the deadliest brain cancer, from spreading in lab mice without harmful side effects. The breakthrough targets a gene that drives the cancer's aggressive spread through the brain.
Patients with glioblastoma, the most aggressive form of brain cancer, finally have new hope. Boston researchers just proved a genetically modified virus can extend survival by helping the immune system attack tumors.
A groundbreaking immune cell therapy caused aggressive brain tumors to shrink dramatically within days in early trials. The treatment offers new hope for glioblastoma, one of the deadliest cancers with few effective options.
Scientists used a genetically modified herpes virus to help immune cells attack glioblastoma, the deadliest brain tumor. Patients in the trial lived longer than expected, offering new hope after 20 years without treatment advances.
A startup is bringing hope to glioblastoma patients with an experimental CAR-T therapy that made all three initial patients' tumors shrink dramatically. One patient remains cancer-free more than 2.5 years after treatment.
University of Virginia researchers have developed a breakthrough approach to treating glioblastoma, the most aggressive brain cancer that kills over 13,000 Americans yearly. Using naturally occurring molecules and innovative delivery methods, they're targeting multiple cancer genes simultaneously without toxic side effects.
Scientists at Oregon State University engineered tiny sugar-coated particles that sneak past the brain's natural defenses to deliver life-saving treatment directly to deadly glioblastoma tumors. In mice, the approach extended survival by 50% with no toxic side effects.
A personalized vaccine safely triggered immune responses in patients with glioblastoma, one of the most aggressive brain cancers. The early trial offers fresh hope for a disease that typically gives patients less than 18 months to live.
A single injection of an engineered virus is finally unlocking the immune system's power against glioblastoma, one of the deadliest brain cancers. Patients treated with the virus lived longer than expected, offering hope after 20 years without new treatment options.
Scientists have developed a gene therapy that completely eliminated aggressive brain tumors in 83% of animal trials, with no recurrence over 11 months. The breakthrough treatment for glioblastoma, the deadliest brain cancer, uses a "Trojan horse" approach that kills cancer cells while training the immune system to fight back.
Researchers at Brown University Health have discovered a molecule that could revolutionize treatment for glioblastoma, one of the deadliest brain cancers. The breakthrough explains why some tumor cells resist chemotherapy while others don't.
Scientists created a nanofiber mesh that delivers three cancer drugs directly to brain tumors, doubling survival time in mice with glioblastoma. The breakthrough offers hope for treating one of the deadliest cancers.
A small trial in Calgary found that high-dose vitamin B3 helped 82% of glioblastoma patients avoid disease progression for six months, compared to the typical 54%. While early and requiring more study, the affordable supplement appears to rejuvenate immune cells to better fight this aggressive cancer.
Becca Valle was given months to live after a glioblastoma diagnosis, but a breakthrough ultrasound treatment helped her become part of a rare 10% who survive past five years. The experimental therapy could transform how doctors treat deadly brain cancers.
A breakthrough gene therapy wiped out aggressive brain tumors in 83% of cases with a single dose and no side effects for nearly a year. The treatment also taught the immune system to prevent the cancer from returning.
Showing 20 of 55